Pharmaceuticals Sector
FTSE 100 shares close lower
Mar 21, 2013 13:18 EDT
London shares closed lower on Thursday as traders looked past positive economic data to focus on bleak eurozone news, notably fallout from the Cyprus bailout impasse.
Drugmaker AstraZeneca announces 2,300 more job cuts
Mar 21, 2013 06:01 EDT
British pharmaceutical company AstraZeneca on Thursday said it was cutting 2,300 jobs on top of the 1,600 losses it announced at the start of the week, in a major restructuring of the group over the next three years.
Malaria vaccine fails to work after four years: study
Mar 20, 2013 17:21 EDT
A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday.
China blasts US court for $162 mn price-fixing award
Mar 19, 2013 12:11 EDT
Beijing lashed out Tuesday at a US court that ordered two Chinese pharmaceutical companies to pay $162 million for price-fixing in the US market, saying the ruling infringed its sovereignty.
Drugmaker AstraZeneca says to cut 1,600 jobs
Mar 18, 2013 11:08 EDT
British pharmaceutical company AstraZeneca on Monday said it would axe 1,600 jobs worldwide in a major restructuring of the group over the next three years.
SAC hedge funds fined $614 mn for insider trades
Mar 15, 2013 19:17 EDT
The SEC announced insider trading fines of more than $614 million Friday for affiliates of billionaire Steven A. Cohen's SAC Capital Advisers, dealing another blow to the embattled hedge fund titan.
SEC fines SAC unit $600 mn over insider trades
Mar 15, 2013 14:53 EDT
The SEC announced Friday it was fining a unit of the hedge fund SAC Capital Advisors more than $600 million over insider trades that netted hundreds of millions of dollars in illicit profits.
FDA studying possible cancer risk of anti-diabetes drugs
Mar 15, 2013 10:09 EDT
The US Food and Drug Administration said Thursday it was reviewing results of unpublished studies hinting at higher risks of ulcers and pancreatic cancer for users of certain anti-diabetes drugs.
Interpol deal with drug firms to fight fake medicines
Mar 12, 2013 14:38 EDT
Interpol on Tuesday announced a deal with the world's top pharmaceutical companies to fight fake drugs which threaten the health of millions, especially in poor countries.
British business backs PM's foreign aid pledge
Mar 11, 2013 06:11 EDT
Chief executives of some of Britain's biggest companies -- including BP, Vodafone and GlaxoSmithKline -- on Monday joined the boss of English football's Premier League in stressing the need for Britain to maintain its overseas aid budget.
US companies keep more money offshore
Mar 11, 2013 01:38 EDT
US companies are keeping more of their profits offshore, choosing overseas tax havens amid talk in Washington about closing corporate tax loopholes, The Wall Street Journal reported Monday.
Big Pharma battle threatens to delay Pacific trade pact
Mar 09, 2013 23:41 EST
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Top US court allows Amgen class action suit
Feb 28, 2013 11:10 EST
The US Supreme Court ruled Wednesday in favor of investors seeking to join a class-action lawsuit against pharmaceutical giant Amgen for downplaying safety concerns about two anemia drugs.
India's Ranbaxy surprises with quarterly loss
Feb 26, 2013 11:33 EST
India's largest drug firm Ranbaxy reported Tuesday a sharp narrowing of its quarterly net loss but missed analyst forecasts for a profit after it was hit by product recall charges.
Biological passports in place for World Cup 2014
Feb 15, 2013 10:46 EST
Every player at the 2014 World Cup in Brazil will be required to have a biological passport, the sport's world governing body FIFA announced on Friday.
Novo Nordisk shares plunge on insulin setback
Feb 11, 2013 13:02 EST
The world's biggest insulin producer Novo Nordisk Monday had 10.7 billion euros ($14.4 billion) wiped off its market value after the company said US authorities had rejected its applications for two new insulin treatments.
Novo Nordisk shares plunges on insulin setback
Feb 11, 2013 06:50 EST
Shares in the world's biggest insulin producer Novo Nordisk plunged by up to 15 percent on Monday after the company said US drug authorities had rejected its applications for two new insulin treatments.
Drugmaker GSK reveals lower profits, restructuring
Feb 06, 2013 13:31 EST
British drugs firm GlaxoSmithKline on Wednesday unveiled a 13-percent drop in annual net profits and outlined a plan for more restructuring in Europe to deliver greater savings and offset weaker sales across the region.
Biogen to pay Elan $3.25 bn for MS drug Tysabri rights
Feb 06, 2013 11:55 EST
American pharmaceuticals firm Biogen Idec is buying the stake held by Irish partner Elan in the multiple sclerosis drug Tysabri for $3.25 billion, the companies said on Wednesday.
GlaxoSmithKline plans revamp as profits drop
Feb 06, 2013 07:59 EST
British drugmaker GlaxoSmithKline on Wednesday announced a 13-percent drop in annual profits and said it would further restructure its European operations to deliver greater savings amid weaker sales across the region.
